• Citing Article List

    The journal uses Crossref Cited-by service counts times cited of published articles. Cited-by allows Crossref members to find out who is citing their content. This is the Citing Article List of “Nonalcoholic fatty liver disease and portal hypertension”.
    No. Publication Date Citing Article
    1 2023 Alba Rojano, Elena Sena, Ramiro Manzano-Nuñez, Juan M. Pericàs, Andreea Ciudin. NAFLD as the metabolic hallmark of obesity, Internal and Emergency Medicine. 2023; 18: 31.  https://doi.org/10.1007/s11739-022-03139-x
    2 2021 Yu‐Ling Sun, Tao Bai, Lin Zhou, Rong‐Tao Zhu, Wei‐Jie Wang, Ruo‐Peng Liang, Jian Li, Chi‐Xian Zhang, Jian‐Jun Gou. SOD3 deficiency induces liver fibrosis by promoting hepatic stellate cell activation and epithelial–mesenchymal transition, Journal of Cellular Physiology. 2021; 236: 4313.  https://doi.org/10.1002/jcp.30174
    3 2023 Li-Li Ren, Xiao-Jun Li, Ting-Ting Duan, Zheng-Hai Li, Jun-Zheng Yang, Ya-Mei Zhang, Liang Zou, Hua Miao, Ying-Yong Zhao. Transforming growth factor-β signaling: From tissue fibrosis to therapeutic opportunities, Chemico-Biological Interactions. 2023; 369: 110289110289.  https://doi.org/10.1016/j.cbi.2022.110289
    4 2021 Csaba Adori, Teresa Daraio, Raoul Kuiper, Swapnali Barde, Lubica Horvathova, Takashi Yoshitake, Robert Ihnatko, Ismael Valladolid-Acebes, Pauline Vercruysse, Ashley M. Wellendorf, Roberto Gramignoli, Bela Bozoky, Jan Kehr, Elvar Theodorsson, Jose A. Cancelas, Boris Mravec, Carl Jorns, Ewa Ellis, Jan Mulder, Mathias Uhlén, Christina Bark, Tomas Hökfelt. Disorganization and degeneration of liver sympathetic innervations in nonalcoholic fatty liver disease revealed by 3D imaging, Science Advances. 2021; 7: eabg5733.  https://doi.org/10.1126/sciadv.abg5733
    5 2022 Joseph Crutison, Thomas Royston. The design and application of a diffusion tensor informed finite-element model for exploration of uniaxially prestressed muscle architecture in magnetic resonance imaging, Engineering with Computers. 2022; 38: 3893.  https://doi.org/10.1007/s00366-022-01690-x
    6 2022 Dan Su, Jian Luo, Junqi Ge, Yali Liu, Chen Jin, Pengfei Xu, Ruowen Zhang, Genhua Zhu, Ming Yang, Zhifu Ai, Yonggui Song. Raw and Wine Processed Schisandra chinensis Regulate NREM-Sleep and Alleviate Cardiovascular Dysfunction Associated with Insomnia by Modulating HPA Axis, Planta Medica. 2022; 88: 1311.  https://doi.org/10.1055/a-1721-4971
    7 2024 Gyorgy Baffy, Piero Portincasa. Gut Microbiota and Sinusoidal Vasoregulation in MASLD: A Portal Perspective, Metabolites. 2024; 14: 324.  https://doi.org/10.3390/metabo14060324
    8 2021 Miren Bravo, Imma Raurell, Aurora Barberá, Diana Hide, Mar Gil, Federico Estrella, María Teresa Salcedo, Salvador Augustin, Joan Genescà, María Martell. Synergic effect of atorvastatin and ambrisentan on sinusoidal and hemodynamic alterations in a rat model of NASH, Disease Models & Mechanisms. 2021; 14: dmm048884.  https://doi.org/10.1242/dmm.048884
    9 2022 Michal Sýkora, Kateřina Cimburová. Pathological changes of a spleen and prevention of infectious complications in asplenic patients, Medicína pro praxi. 2022; 19: 202.  https://doi.org/10.36290/med.2022.032
    10 2023 Monika Adori, Sadam Bhat, Roberto Gramignoli, Ismael Valladolid-Acebes, Tore Bengtsson, Mathias Uhlèn, Csaba Adori. Hepatic Innervations and Nonalcoholic Fatty Liver Disease, Seminars in Liver Disease. 2023; 43: 149.  https://doi.org/10.1055/s-0043-57237
    11 2023 Raymond A. Isidro, Lei Zhao. Evolving Understanding of Noncirrhotic Portal Hypertension, Surgical Pathology Clinics. 2023; 16: 549.  https://doi.org/10.1016/j.path.2023.04.009
    12 2023 Stan Bukofzer, Geoffrey Harris, Susan Song, Edward E Cable. OCE-205, a Selective V1a Partial Agonist, Reduces Portal Pressure in Rat Models of Portal Hypertension, Journal of Experimental Pharmacology. 2023; Volume 15: 279.  https://doi.org/10.2147/JEP.S416673
    13 2023 Eric Felli, Sonia Selicean, Sergi Guixé-Muntet, Cong Wang, Jaume Bosch, Annalisa Berzigotti, Jordi Gracia-Sancho. Mechanobiology of portal hypertension, JHEP Reports. 2023; 5: 100869100869.  https://doi.org/10.1016/j.jhepr.2023.100869
    14 2024 Anita Madir, Ivica Grgurevic, Emmanuel A Tsochatzis, Massimo Pinzani. Portal hypertension in patients with nonalcoholic fatty liver disease: Current knowledge and challenges, World Journal of Gastroenterology. 2024; 30: 290.  https://doi.org/10.3748/wjg.v30.i4.290
    15 2024 Emma Hajaj, Ahinoam Glusman Bendersky, Marius Braun, Amir Shlomai. 2024;   https://doi.org/10.1101/2024.10.26.24316188
    16 2022 Amedeo Lonardo, Alessandro Mantovani, Giovanni Targher, Gyorgy Baffy. Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease: Epidemiology, Pathogenesis, and Clinical and Research Implications, International Journal of Molecular Sciences. 2022; 23: 13320.  https://doi.org/10.3390/ijms232113320
    17 2022 Cosmas Rinaldi A. Lesmana, Maria S. Paramitha, Irsan Hasan. 2022; 475.  https://doi.org/10.1016/B978-0-12-819265-8.00079-6
    18 2021 Cosmas Rinaldi Adithya Lesmana, Maria Satya Paramitha, Irsan Hasan, Andri Sanityoso Sulaiman, Rino Alvani Gani. Portal Hypertension in Non-alcoholic Fatty Liver Disease in the Era of Non-invasive Assessment, European Medical Journal. 2021; 80.  https://doi.org/10.33590/emj/21-00039
    19 2021 Véronique V. van Cooten, Daan J. de Jong, Frank J. Wessels, Pim A. de Jong, Madeleine Kok. Liver Enhancement on Computed Tomography Is Suboptimal in Patients with Liver Steatosis, Journal of Personalized Medicine. 2021; 11: 1255.  https://doi.org/10.3390/jpm11121255
    20 2021 Guido Costa, Lara Cavinato, Chiara Masci, Francesco Fiz, Martina Sollini, Letterio Salvatore Politi, Arturo Chiti, Luca Balzarini, Alessio Aghemo, Luca di Tommaso, Francesca Ieva, Guido Torzilli, Luca Viganò. Virtual Biopsy for Diagnosis of Chemotherapy-Associated Liver Injuries and Steatohepatitis: A Combined Radiomic and Clinical Model in Patients with Colorectal Liver Metastases, Cancers. 2021; 13: 3077.  https://doi.org/10.3390/cancers13123077
    21 2023 Joy Ito, Hector Lemus, Tianying Wu. Serum Phosphorus, Serum Bicarbonate, and Renal Function in Relation to Liver CYP1A2 Activity, Diagnostics. 2023; 13: 2996.  https://doi.org/10.3390/diagnostics13182996
    22 2024 Eden Hornung, Sirisha Achanta, Alison Moss, James S. Schwaber, Rajanikanth Vadigepalli, Tomohiko Ai. Multi-organ gene expression analysis and network modeling reveal regulatory control cascades during the development of hypertension in female spontaneously hypertensive rat, PLOS ONE. 2024; 19: e0313252.  https://doi.org/10.1371/journal.pone.0313252
    23 2022 Max Kabolowsky, Lyndsey Nguyen, Brett E. Fortune, Ernesto Santos, Sirish Kishore, Juan C. Camacho. Interventional Management of Portal Hypertension in Cancer Patients, Current Oncology Reports. 2022; 24: 1461.  https://doi.org/10.1007/s11912-022-01319-8
    24 2023 Xinyu Wang, Shuhang Wei, Yingnan Wei, Xueqi Wang, Feng Xiao, Yuemin Feng, Qiang Zhu. The impact of concomitant metabolic dysfunction-associated fatty liver disease on adverse outcomes in patients with hepatitis B cirrhosis: a propensity score matching study, European Journal of Gastroenterology & Hepatology. 2023; 35: 889.  https://doi.org/10.1097/MEG.0000000000002583
    25 2024 William S. Reiche, Ryan W. Walters, Bryce F. Schutte, Sandeep Mukherjee, Haitam M. Buaisha. Mild Thrombocytopenia, a Predictor of Outcomes After Laparoscopic Cholecystectomy, Journal of Clinical Gastroenterology. 2024; 58: 507.  https://doi.org/10.1097/MCG.0000000000001926
    26 2023 Matteo Boninsegna, Peter A. G. McCourt, Christopher Florian Holte. The Computed Sinusoid, Livers. 2023; 3: 657.  https://doi.org/10.3390/livers3040043
    27 2023 Piero Portincasa, NAFLD, MAFLD, and beyond: one or several acronyms for better comprehension and patient care, Internal and Emergency Medicine. 2023; 18: 993.  https://doi.org/10.1007/s11739-023-03203-0